Pfizer and Moderna Stocks: Down 30% and 27% – Buy and Holdby Terry Bingman 06.04.2024Pfizer and Moderna have struggled in the stock market, but Pfizer has a substantial pipeline of programs. Moderna's success is ...
BioVaxys Acquires IMV’s Immunotherapy Tech for Growthby John Darbie 13.02.2024BioVaxys Technology Corp. finalizes agreement to acquire IMV Inc.'s immunotherapy technology portfolio, expanding its cancer vaccine portfolio and positioning itself ...